EvenUp vs Supio: pricing, features and which to choose

Founded in 2019 by Rami Karabibar, Raymond Mieszaniec, and Saam Mashhad, EvenUp develops software for plaintiff-side personal injury practices. The company announced a $150 million Series E in October 2025, bringing reported funding to $385 million and its valuation above $2 billion. EvenUp says more than 2,000 firms use its platform, including 20 percent of the Top 100 United States personal injury firms. It also says customers have resolved more than 200,000 cases representing over $10 billion in damages. The company remains headquartered in San Francisco. Its focused design suits personal injury teams handling substantial medical documentation, but it offers less value to general commercial practices seeking broad legal research, transactional drafting, or unrelated case-management workflows.

A matter can begin with medical records, bills, correspondence, and other documents uploaded to the platform. Piai extracts treatment details, organizes provider information into a timeline, and identifies liability, damages, and missing material. Teams can create demand letters, medical summaries, complaints, negotiation sheets, interrogatory responses, and related drafts. Express Demands can assemble exhibits and retain line-level references. Firms can choose AI-generated work or a professional review option involving EvenUp legal professionals. Smart Workflows flags treatment gaps, missing documents, and timing issues. Case Financials and Medical Bill Summary help staff examine charges against policy limits. Attorneys remain responsible for verifying facts, revising documents, and making legal decisions before using any output.

EvenUp's main drawback is commercial opacity. The company describes its products and case-based model, but does not publish plan prices, public usage quotas, a self-serve API, or a standard trial. Eve is a close personal injury competitor with intake, case evaluation, drafting, and litigation workflows. Supio focuses on medical-record analysis, chronologies, and plaintiff case documents. DigitalOwl concentrates on structured medical-record review rather than a complete demand workflow. EvenUp is a strong fit for a personal injury firm seeking medical analysis, demands, financial review, and task alerts from one vendor. It is less suitable for buyers requiring published rates, broad legal research, or autonomous work without attorney checking.

Supio is a Seattle legal AI company focused on personal injury and mass tort plaintiff firms. It emerged from stealth in August 2024 with a $25 million Series A, then announced a $60 million Series B on April 30, 2025, bringing reported total funding to $91 million. Sapphire Ventures led the Series B, with Mayfield and Thomson Reuters Ventures participating. Supio is built for firms processing substantial case records and portfolios, rather than for general legal question answering. Its named workflows include chronologies, demand letters, case ledgers, litigation drafting, intake, and agentic case operations. The company describes specialized, purpose-built AI models and human expert verification, but does not name the foundation model vendors behind the service.

Supio organizes case preparation around document intelligence and structured outputs. Case Economics, Case Signals, and the Drafting Suite address different stages of reviewing records and producing work product. Teams can create chronologies, demand letters, case ledgers, and litigation drafts. Supio Intake conducts intake around the clock, scores leads, and writes structured case data to a case-management system. Supio Agent, launched in May 2026, plans and executes finished work with attorney oversight at case, portfolio, and firm levels. Connectors support integrations and two-way CMS synchronization, while a Westlaw Advantage connection was announced in April 2026. The practical design is a shared operating layer for case preparation, lead handling, and drafting, rather than a single document-generation utility.

The main buying risk is opacity around commercial and technical details. Supio does not publish dollar prices, named model vendors, API limits, retention schedules, or self-hosted deployment options. EvenUp is the closest specialist comparison, covering plaintiff-injury intake, treatment, demands, negotiation, discovery, and trial, with MedChrons combining AI and professional or nurse review. Filevine’s LOIS is broader case-management software that acts on matters, deadlines, documents, and appointments inside its system of record. Litify combines Salesforce-based practice management with agentic workflows and a Supio-powered damages assistant. Supio should be picked by plaintiff firms wanting dedicated case intelligence, intake, drafting, and portfolio automation, provided a custom quote and contract answer their integration and governance requirements.